-
The sluggish sales of COVID-19 Pharmaceutical delayed the performance, and Pfizer plans to cut billions of dollars in expenditure, announcing global layoffs
The once popular Pfizer COVID-19 medicine has gone unnoticed. Recently, Pfizer announced that its oral drug Paxlovid, an anti COVID-19 drug, will be converted to self funded mode. Meanwhile, the pric ...